Aims This is a meta-synthesis of extant qualitative literature related to impact of continuous glucose monitoring (CGM). CGM has been available for a decade for the management of Type 1 diabetes and is the lynchpin of future artificial pancreas technologies. Clinical uptake of CGM is an important area of inquiry. The purpose of this metasynthesis is to understand the impact of CGM on individuals with Type 1 diabetes and others (parents, significant others, providers) in order to design appropriate clinical interventions for adherence.
Introduction
Enormous advances in the treatment of Type 1 diabetes mellitus have been made in the past decade, with new and sophisticated technologies coming to the forefront of care. Continuous glucose monitors (CGM) became commercially available in the middle of the first decade of the 21st century, and have been shown to improve long-term glycaemic outcomes as well as reduce incidence of hypoglycaemia [1] [2] [3] . CGM systems comprise a subcutaneous glucose sensor, a transmitter affixed to the skin and attached to the sensor, and a wireless receiver or mobile phone that displays the glucose results every 5 min. They are often coupled with an insulin pump to minimize the number of devices.
CGM utility is increasing dramatically with new applications. Until very recently, CGMs have been adjunctive therapy to standard blood glucose monitoring [4] . This changed in 2016 when the USA approved the Dexcom G5 System for replacement of blood glucose testing [5] . Further, CGM is a lynchpin of automated insulin delivery systems, including low and predicted low glucose suspend, hybrid closed-loop and full artificial pancreas technologies [6, 7] .
iterations reported poor user satisfaction [8] and adherence [9] , although the subsequent JDRF CGM randomized trial showed 95% of research participants still wearing their CGM at 6 months [10] , with moderately high satisfaction [11] . Many reports indicate favourable impressions of the technology [11] [12] [13] including perceived benefits of hypoglycaemia prevention [11, 13, 14] , improvement of diabetes control [13, 15, 16] , safety during sleeping and exercising [16, 17] , the ability to see glucose trends in real time [11, 18] and overall increased quality of life [13, 15] .
In real-world clinical care, however, the CGM experience is mixed, with many users having difficulty sustaining use over time [1, 19, 20] . Recent registry data in the USA indicate CGM usage at < 10% in adolescents and young adults, and peaking at 23% in adults aged 26-49 years [20] . CGM uptake around the world is highly varied due to healthcare payer systems, device availability and overall expense. Recent studies also show poor continuation of CGM in critical populations such as those with impaired hypoglycaemia awareness [21] . Identified barriers to routine CGM use include accuracy [17, 22] , inadequate reimbursement/cost [16, 17, 22] , educational needs [22] , frequent annoyances from alarms, insertion pain, body issues [11] and interruptions to daily life [13, 15] . A newer species of CGM recently became available with the Freestyle Libre Flash Glucose Monitoring System. This system does not provide real-time CGM readings or temporal alerts, and is therefore not included in this synthesis.
With CGMs playing a crucial role in present and future diabetes care, why are not more people using them? One approach to understanding this dilemma is to synthesize extant qualitative literature related to people's experiences with CGM. Qualitative studies lend unique nuanced viewpoints, speaking in ways that detached satisfaction surveys cannot. Qualitative research further provides responses in context, and when aggregated and synthesized, can transfer knowledge. Through a qualitative lens, this meta-synthesis aims to answer the question of how CGM impacts the lives of people with Type 1 diabetes.
Methods
This study is a qualitative meta-synthesis of the extant literature that included a systematic literature search, quality appraisal process [23] , thematic synthesis [24] and reciprocal translation [25] [26] [27] , and the reporting of analytic themes to address the question in line with established standards [28, 29] .
Data sources and searches
The literature search was conducted in February/March 2017. PubMed, PsychINFO, CINAHL, Web of Science and EMBASE databases were queried, limiting publication dates to 2007-2017. This period reflects a time when CGMs were commercially available and increasingly used in clinical care. Publications were also limited to the English language. Search terms included 'Type 1 diabetes', 'CGM', 'continuous glucose monitoring', 'experience' and 'qualitative' (e.g. 'Type 1 diabetes' AND CGM AND qualitative). The search process is detailed in Fig. 1 .
Study selection
Articles were selected for inclusion by the first author if they contained original qualitative or mixed-method research related to CGM use. Review articles, editorials, and grey literature (issue papers, government reports, etc.) were excluded from the final yield. Articles that included CGM as part of more complex technologies (sensor-augmented pump, artificial pancreas systems) were included and evaluated for qualitative data that could be distinctly tied to the CGM component of the system. Data not related to CGM (insulin pump use, artificial pancreas functionality), or where the topic was ambiguous were not analysed.
Data extraction and quality assessment
The articles that met inclusion criteria were analyzed for quality attributes by a registered nurse/certified diabetes educator and a licensed clinical social worker. First step in the appraisal was immersion in the articles, providing a close reading and consideration of each study as a whole. We used the quality appraisal tool designed by Letts and colleagues for formal analysis of qualitative studies [23] . The instrument evaluates 17 domains of quality that relate to study design, qualitative methodology, sampling, data collection, data analysis and rigour.
Data synthesis and analysis
We used a structured team-based meta-synthesis approach [25] called interpretive thematic synthesis that involved What's new?
• Continuous glucose monitoring (CGM) is the cornerstone of future diabetes technologies, and it is essential that healthcare providers comprehend the user experience with CGM in order to promote sustained use.
• This qualitative meta-synthesis synthesizes nine studies (343 participants) to provide a meaningful picture of the impact of CGM: interacting with CGM, emotional burden, feeling different, feeling empowered, using glucose information and affecting relationships.
• This synthesis identifies targets for intervention including optimizing CGM settings, discussing empowerment strategies, and forming partnerships with parents, significant others and providers.
extracting salient information about the study, developing descriptive data-driven themes and then synthesizing themes through a process called reciprocal translation [24, 26] . First, each study was analyzed to determine study purpose, setting, design, methods, participants and findings. Next, the studies were assessed for thematic content. In this approach, the entire qualitative content of the articles was considered data (excluding quantitative data in mixed-method articles). This included both participant quotations and author interpretations. A list of themes related to the impact of CGM was generated by the first and second authors, and the articles were read again for consensus of proposed themes. This process was repeated multiple times. Themes from studies that included combined devices (sensor-augmented pump, automated insulin systems) were carefully screened and only included if our clinical judgement suggested the theme related specifically to CGM (e.g. transmitter size) and not the system as a whole. Themes from individual articles were indexed in chart form with similar themes across other articles, creating a comprehensive picture of pervasive concepts. Individual study themes were therefore categorized and interpreted in light of concepts in other studies. This process of 'translating' concepts from one study to another is used to synthesize qualitative data across studies [24, 26] . We aggregated the newly derived themes into the final reciprocal translation 
Results
The initial search for 'Type 1 diabetes' and 'continuous glucose monitoring' yielded 1469 articles (Fig. 1) . With the addition of search term 'experience', 71 articles were retrieved, and further refined to by excluding reviews, editorials and articles unrelated to individuals' experiences with CGM. Of the 25 remaining articles, 18 were excluded for quantitative methodology, 5 for not being directly relevant to CGM and 2 being selected for further review. When the initial search was repeated with 'qualitative' as the refining search term, 13 articles were found, reduced to 10 research based articles, and 7 selected for further review. Search 2 and 3 combined yielded a total of nine articles included in this meta-synthesis [14, 16, 18, [30] [31] [32] [33] [34] [35] . Key features of the articles including study design and population characteristics are summarized in [14, 16, 18, 30, 33] , one on sensor-augmented pump therapy [31] and three on artificial pancreas systems [32, 34, 35] . Three of the studies were conducted in the UK [16, 34, 35] , three in the USA [14, 18, 33] , and one each in Australia [30] , Canada [31] and the Netherlands [32] .
All nine articles had a clearly articulated purpose, literature review, appropriate human subjects ethics statement, Only one paper cited a theoretical perspective (technology acceptance model), which also led to pre-determined themes that were not derived in an inductive manner [32] . Procedural rigour was described in two papers [14, 30] . Descriptions of overall rigour were mixed with two papers lacking detail about credibility, transferability, dependability and confirmability [32, 35] .
The meta-synthesis reciprocal translation process resulted in six derived themes describing how CGM impacts the lives of users (Table 2 ). These themes were not isolated to a single viewpoint (CGM user, significant relationship or healthcare provider), rather corroborated across many viewpoints and ages. All six themes provide contextual understanding of how CGM influences daily life, and are reported here in nonhierarchical order. The six new themes are: (1) interacting with CGM, (2) burden of living with CGM, (3) feeling different from others, (4) feeling empowered by CGM, (5) interacting with glucose levels and (6) impact on relationships.
Theme 1: Interaction with CGM
Interacting with the physical CGM device significantly impacts life, which ties closely with the burden of CGM theme. 'Interacting with CGM' relates primarily to kinaesthetic requirements like inserting glucose sensors, wearing the sensor and transmitter on the body, responding to alerts by pushing buttons on the device, or navigating CGM menus for troubleshooting measures. The four subthemes derived here are: impact of device size, pain, troubleshooting system and alarms. CGM users are impacted by the size of the device [31] [32] [33] [34] [35] . The CGM transmitter is particularly large and disruptive, more than an insulin pump infusion set which is similarly affixed to the skin [31, 33, 35] . This lead to discomfort while sleeping, having to position oneself carefully and concern about pulling out the sensor/transmitter unit at night [33, 34] . There was also concern about dislodging the sensor/transmitter on the body through everyday activities such as exercise or sports [33] . CGM and diabetes are never far from the mind of a CGM user who has a bulky device affixed to the body that must be protected from bumping and dislodging.
Pain and discomfort from the CGM are endorsed by many CGM users [16, 31, 34] . Adults and children with Type 1 diabetes already contend with painful self-management activities such as insulin injections, and CGM is another device that can cause pain upon insertion as well as occasionally during wear. This was reported in both adolescents [31, 34] and adults [16] who wear CGM. Further, skin sensitivities cause additional irritation and pain for CGM users [31] , leading to a cycle of discomfort, sensor rotation and skin healing. The subthemes of troubleshooting and CGM alarms reveal complexity in the 'interacting with CGM' theme. Both these tasks compel a kinaesthetic response from the user (silencing alerts, checking glucose levels, etc.), and also may lead to emotional frustration with the device. Troubleshooting is defined as mitigating problems with the device (e.g. calibration errors or sensor errors) [31] [32] [33] , and frustration when equipment fails [34] . Troubleshooting CGM compounds frustration and annoyance because even in its absence, CGM can be a high-maintenance companion.
Alarms are considered a separate subtheme because they can be part of appropriate CGM functioning (e.g. hyperglycaemia alerts), however still require user intervention [16, 18, [31] [32] [33] 35] . 'Frustrating' was a widespread descriptor of the impact of frequent CGM alarms [16, 18, 31, 33] , to the point of them being exceedingly distracting or even a reason for discontinuing the system. [18] . Alert fatigue can cause CGM users to ignore alerts and reduce trust in device use. However, CGM alerts were also described by some CGM users as helpful for driving a car, working or using at school [16] . Whether the user perceived the alerts as helpful or nuisance related to frequency of the alerts as well as perceived utility for the situation. The emotional burden of diabetes can be exacerbated by CGM use [16, 31, 35] . The constant nature of CGM feedback can make the user can feel anxious, as if the CGM is taking over their life [16] . A parent of an adolescent CGM user expressed the total overwhelming nature of the device like this:
Like any technology it's one more added thing. It's one more thing he has to insert, so now he has two things connected to him. It's one more thing we have to buy. It's one more thing we have to trust to help us manage his diabetes. It's one more thing to talk about. It's one more thing to troubleshoot. It's just one more thing that you have to learn to incorporate into everything else that goes on in a family from the time you wake up in the morning to showers, to catching the bus, little things that people do every day without having to add this to it. So it's added discussion in the family, to management of his diabetes [31] .
This emotional burden of CGM adds an unrelenting and continual reminder of diabetes.
Another CGM burden is alteration in sleep [16, 33] . Although some CGM users felt they could sleep more easily [16, 33] , others conveyed more disrupted sleep, likely due to the frequency of both safety and troubleshooting alarms [16] . Sleep is already an ongoing struggle for children and adults with Type 1 diabetes, and CGM adds another variable to be handled on a nightly basis.
Finally, cost is a significant burden with CGM [16, 30, 31, 33] , and noted in respondents across several international healthcare systems. Adults reflect concern about maintaining CGM use over time due to the financial burdens [16] , whereas adolescents expressed worry about losing an expensive device [31, 33] . CGM users in multiple countries were confused over payer coverage as well [16, 33] . Diabetes educators in Australia reflected that CGM systems are unaffordable for many people, and that CGM training time is poorly reimbursed [30] . Overall, concerns about expense affected CGM experience on multiple levels (user to provider), adding financial complexity to already costly diabetes care.
Theme 3: Feeling different from others
People with diabetes often feel different from those without diabetes, and CGM can exacerbate these feelings. CGM can make diabetes visible to others, and alter the person's body image.
CGM users can experience heightened concern about other people knowing they have diabetes [16, 18, 31, 33, 35] . The physical profile of the CGM transmitter is difficult to hide under clothes, making diabetes more visible to others [18] . CGM can further lead to social worries about alarming at inconvenient times, causing unwanted attention and a sense of being different [31, 33, 35] . Although the majority outlook was that CGM made diabetes more difficult to conceal, performing fewer blood glucose tests allowed some aspects of diabetes to be concealed better for some users [16] .
CGM users may also experience altered perceptions of body image. CGM users describe feeling self-conscious about their appearance because of CGM [18] . Another descriptor was feeling robotic, or others perceiving the CGM user as having a machine-like extension to their body [18] . This was exemplified by a 55-year-old woman describing her selfconsciousness when her spouse looked at her naked:
Physically he found it odd to be looking at it on my body, especially since I had the pump on one side and the monitor on the other . . . I called myself the Bionic Woman at that point . . . I would want the lights out, a little more often [18] .
This differs from the visibility theme because it more intrinsically affects the wearer's sense of self in relation to the device. Wearing complex technologies on the body changes how the user experiences their own body as well as how others experience it.
Theme 4: Feeling empowered
Empowerment is a positive theme noted among CGM users, with subthemes including security/reassurance and independence.
CGM affords users a sense of security about diabetes that is not possible without ongoing monitoring. CGM users describe feeling safer while wearing CGM, which enables them to live with less fear of unexpected hypoglycaemia [16] . Further, CGM gives reassurance to the wearer during daily activities [33] . Spouses or significant others also benefit from less worry about severe hypoglycaemia events [14, 18] . Overall, both personal security and security of loved ones can be a significant benefit to CGM.
A sense of independence and personal control may be heightened with CGM use [14, 16, 31] . CGM allows confidence in independent activities that previously caused concern for self or significant others such as taking solo vacations or driving [14] . Independence and autonomy are especially pertinent to children with Type 1 diabetes, and CGM can foster increased autonomy [31] . A parent of a 5-year-old CGM user articulated this by saying, . . . he feels more in control of his own body. He loves it and says it is his best friend. It gives him the freedom to be in another room and not feel 'watched' which helps him gain confidence. When we don't have sensors on, it feels so much more terrifying for us all and my son hates feeling out of control. It gives him a 'voice' if that makes sense [16] .
In addition, parents felt more comfortable with their child's independence at school or a friend's house [16] . Overall, CGM helps both the user and parents feel confident about glucose monitoring, allowing more emotional and physical independence and delegation to other caregivers. CGM use leads to increased glucose information to contend with, and subthemes include managing the information from CGM, achieving better glucose control, and questioning the reliability of CGM.
Whereas non-CGM users may check glucose levels between two and eight times per day, CGM users receive 288 glucose levels each day. Managing this information can be both helpful and overwhelming [14, 16, 18, 30] . CGM enlightens the user to real-time glucose trends, and can help them ameliorate hypo-and hyperglycaemia [18, 30] . Trend information allows anticipatory insulin dosing and minimizes frequency of blood glucose checking. [16] . Retrospective data was also cited as important for insulin dose adjustments, food intake and overall pattern assessment [18] . Spouses/significant others described CGM data as helpful for pregnancy planning and a better overall understanding of diabetes [14] . Making sense of the vast amount of data can be a struggle for CGM users as well, with some describing a lack of confidence in understanding all the information [18] Diabetes educators echoed their own concern with interpreting reports correctly as well as not always having the right downloading equipment, rendering data less beneficial at clinical visits [30] . Overall, the sheer amount of data is significant, and users must make individual value judgements as to how to utilize the information.
Better glucose control can be achieved with CGM [16, 18, 31, 33] by helping manage unpredictable glucose levels, detect hypoglycaemia, manage exercise and make dietary choices [16, 33] . Reducing hypoglycaemia and the incidence of severe hypoglycaemia were also noted as a benefit of CGM information [16] . Users described seeing trends and making adjustments to obtain better glucose control from retrospective information [18, 33] . Users of a sensor-augmented pump suggested that although the insulin pump helped with feeling normal, CGM directly helped with keeping glucose levels under control [31] .
Trust, reliability and sensor accuracy all influence how useful CGM is perceived to be [14, 16, 31, 34] . CGM accuracy is reliant on the quality of user calibrations, and CGM does not always display accurate information [16, 34] . Many CGM users reflected a tolerance for occasional inaccuracy, explaining that the precision was not as important as the trend information, which was more useful [16] . This was perceived as problematic when the actual glucose level was below the CGM reading, or symptoms of hypoglycaemia were present [16] . Point-by-point accuracy is not always possible with CGM, and users learn to value trend information in addition to discrete values.
Theme 6: Impact on relationships CGM users experience altered relationships with spouses, caregivers and healthcare providers due to CGM use. Subthemes include positive and negative impact on spousal relationships, child-parent relationships and healthcare provider relationships.
Many spouses are supportive of CGM use, and appreciate the additional insight they gain into their partners' diabetes [14, 18] . CGM users can share some of the burden of Type 1 diabetes as the spouse gains insight into glucose trends and diabetes management. This was experienced as an increased intimacy in the relationship, and a sense of partnership in carrying the diabetes load [14, 18] . An adult woman who wears CGM expressed this sentiment by stating, 'I think it's (CGM) brought me and my husband closer together because we're sharing the experience of diabetes. It's not just me alone on this uphill trek, where it's all on me. I feel like I'm getting help' [14] . By contrast, some users express the opposite sentiment about their spouse, finding that the spouse did not interact with the CGM, or did not have a firm understanding of the glucose information [18] . CGM is another tool for diabetes care that can either engage a significant other as a partner in diabetes care, or provide little relational benefit.
The parent-child relationship is also impacted by CGM [16, 31] . Similar to spouses, CGM may benefit the relationship between the child with diabetes and the parent, but not always [31] . Parents expressed less stress related to diabetes due to the CGM [16] . Beneficial and supportive parental behaviours include parents establishing themselves as a resource, providing advice if asked, and initiating constructive, non-judgemental conversations [31] . Unhelpful parent behaviours included quizzing or interrogating children about their CGM readings, asking the child 'what had they done wrong', or making the child feel like the CGM was 'spying' on them [31] . The context of the family dynamics contributes greatly to how CGM is incorporated into relationships. CGM can be a helpful mediator of freedom and independence like a trusted best friend, or can lead to increased conflict as if the sensor is spying on diabetes care [31] .
Finally, the relationship with healthcare providers is impacted by the decision to use CGM [16, 30] . Hospitals and healthcare providers are not always knowledgeable about CGM, and have tried to dissuade individuals with Type 1 diabetes from using it. One parent described a negative reaction and outright anger from the hospital when they decided to purchase the CGM [16] . Another adult CGM user described teaching her diabetes team about CGM because they did not understand the technology or its benefits [16] . Diabetes educators expressed that CGM can be overwhelming for them, and that they do not always have the time or staffing necessary to interpret the data [30] . CGM data are also difficult to interpret for many providers, leading to increased negative feelings [30] . Overall, provider ambivalence toward CGM may introduce new and complicated dynamics between individuals using CGM and their providers.
Discussion
This qualitative meta-synthesis fills a gap in the extant literature by synthesizing the qualitative CGM experience of 343 individuals. These results demonstrate that the impact of CGM is multifaceted, and inexorably links the physical consequences of CGM with the emotional and relational consequences of CGM. There are many perspectives represented in this synthesis including adult and adolescent CGM users, parents and spouses of CGM users, and diabetes educators. Together, their accounts create a rich illustration of how CGM affects those living with Type 1 diabetes.
The synthesized qualitative experience introduces highly practical concepts on which to base clinical interventions to increase sustainability of CGM use. The identified burdens and benefits in this synthesis can be leveraged by clinicians to provide targeted education, troubleshooting and expectationsetting. For example, alarm settings can be personalized to provide truly useful alerts and reduce nuisance, a tension described by others as the balance between safety and human factors/usability of the device [36] . An individual with impaired hypoglycaemia awareness may benefit from aggressive tuning of hypoglycaemia alerts, while turning off hyperglycaemia alerts to reduce burden. A self-conscious adolescent may be educated on discrete sensor placement on alternative sites like the hip. Clinicians can make informed recommendations by inquiring how individuals use CGM data, as this has been shown to vary greatly from person to person [37] . Overall, these synthesized themes should be leveraged by both clinicians and individuals with Type 1 diabetes to set realistic goals and expectations for long-term use.
The empowerment theme in this synthesis can also be used to maximize user experience with CGM. Empowerment has previously been suggested as a benefit of CGM [38] , and holds potential as an intervention target for people who have CGM available to them but are struggling to use it. CGM can bolster the confidence of children and parents alike by providing safety and reassurance. CGM may be used as a tool to reduce negative interactions between caregivers and youth, and instead foster new partnership dynamics. For adults, CGM may reduce diabetes-related worry in spouses/ significant others. Although other themes in this synthesize indicate difficulties related to CGM use, the benefits should receive deliberate (though not singular) attention from clinicians to help individuals consider gains they might not have otherwise anticipated.
Although cost is only a subtheme in this analysis, it warrants universal consideration. Reimbursement for CGM is highly varied across the world: the UK endorses CGM only for special circumstances such as severe hypoglycaemia, impaired hypoglycaemia awareness or a persistent HbA 1c > 75 mmol/mol (9%) despite frequent blood glucose checks [39] . Some countries provide more extensive payer coverage in private and governmental sectors (e.g. Switzerland, Germany, USA), whereas others are substantially more limited or absent (e.g. France, Slovenia, Spain) [40] . Although user experience with the physical device does not change based on financial burden, access and potential for continuation of therapy can affect the entire CGM experience, and should be carefully assessed before CGM initiation. The UK approach of approving CGM therapy for certain circumstances may be a helpful guideline for healthcare providers as they weigh the utility of CGM for individuals with Type 1 diabetes.
The reimbursement issue ties in closely with the subtheme of impact on relationship with healthcare providers since they must weigh the financial burden of CGM for individuals. Clinician knowledge base of CGM should not be a rate limiter for access to this technology. Provider guidance may be informed by national or regional healthcare standards, but should also include the perspectives gained from CGM users such as those presented here. It is incumbent on clinicians to provide informed and realistic guidance on CGM therapy to reduce one systemic barrier to CGM use.
Our synthesis has implications for the success or failure of automated insulin delivery. The qualitative themes in this synthesis are amplified when CGM must be worn continuously as part of automated insulin systems, and will be expanded further as the device functionality increases. This will add new burden to the CGM user, while simultaneously providing benefits associated with optimized insulin dosing. Qualitative studies on long-term automated insulin delivery system use will reveal new insight into these experiences.
This qualitative synthesis also highlights important gaps in knowledge. Further in-depth enquiry should explore the parent-child relationship to determine ways to enhance partnership and successful CGM use in children. Overall support structures and the behaviours of significant others and peers should be explored to determine the impact on the CGM user. Although there are some qualitative data available on diabetes educator perspectives on CGM [30] , it is only representative of educators in Australia, and does not include information on other diabetes providers and diverse settings. More information could be ascertained on providers around the world who prescribe and work with CGM. There is also little qualitative data on the impact of CGM on relationships outside spouses and parents. These are interesting areas of further inquiry.
Qualitative meta-synthesis has both strengths and limitations as rigorous systematic work adhering to qualitative principles [25, 28, 41] . The thematic synthesis employed here draws on clinical and research expertise of each of the team members. Analytic strategies were employed across individual studies and then as a collective, using re-contextualizing approaches, research and clinical expertise. The six emergent themes should be considered for meaning in light of other extant literature. Similar themes were found in studies published after this meta-synthesis, including concerns about sensor accuracy in pregnant women [42] , handling CGM information and alerts in adults with impaired hypoglycaemia awareness [43] , and feelings of safety and security in older adults with Type 1 diabetes [44] . This indicates thematic transferability and a meaningful shared experience of CGM across disparate populations.
The results of this study should be considered within the context of its limitations. The sampled population is significantly heterogeneous, with some individuals experiencing CGM alone, or in combination with an insulin pump or automated insulin delivery system, which may have altered the CGM experience. We relied on our clinical expertise to determine the qualitative aspects that related specifically to CGM, and erred on the side of caution when interpreting themes from these participants. Themes of security, cost, better glucose control, etc. could not be extracted from these papers because of the confounding of the automated insulin delivery. Fundamentally, people using CGM clinically may have different experiences and impressions of the device than people participating in research studies.
Overall, living with CGM bestows unique physical, emotional and relational challenges on the user. Individuals must navigate these challenges within their personal lives and make the CGM work within its context. This qualitative meta-synthesis affords insight into these challenges and may help caregivers, spouses, and providers support CGM users in their daily diabetes regimens.
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